HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation.

Abstract
FGF1 and FGF2 bind to specific cell-surface tyrosine kinase receptors (FGFRs) and activate intracellular signaling that leads to proliferation, migration or differentiation of many cell types. Besides this classical mode of action, under stress conditions, FGF1 and FGF2 are translocated in a receptor-dependent manner via the endosomal membrane into the cytosol and nucleus of the cell. However, despite many years of research, the role of translocated FGF1 and FGF2 inside the cell remains unclear. Here, we reveal an anti-apoptotic activity of intracellular FGF1 and FGF2, which is independent of FGFR activation and downstream signaling. We observed an inhibition of cell apoptosis induced by serum starvation or staurosporine upon treatment with exogenous FGF1 or FGF2, despite the presence of highly potent FGFR inhibitors. Similar results were found when the tyrosine kinase of FGFR1 was completely blocked by a specific mutation. Moreover, the anti-apoptotic effect of the growth factors was abolished by known inhibitors of the translocation of FGF1 and FGF2 from the endosomes to the interior of the cell. Interestingly, FGF2 showed higher anti-apoptotic activity than FGF1. Since FGF2 is not phosphorylated by PKCĪ“ and is present inside the nucleus longer than is FGF1, we speculated that the different activities could reflect their diverse nuclear export kinetics. Indeed, we observed that FGF1 mutations preventing binding to nucleolin and therefore phosphorylation in the nucleus affect the anti-apoptotic activity of FGF1. Taken together, our data indicate that the translocation of FGF1 and FGF2 protects cells against apoptosis and promotes cell survival.
AuthorsMichal Kostas, Agata Lampart, Joanna Bober, Antoni Wiedlocha, Justyna Tomala, Daniel Krowarsch, Jacek Otlewski, Malgorzata Zakrzewska
JournalJournal of molecular biology (J Mol Biol) Vol. 430 Issue 21 Pg. 4087-4101 (10 19 2018) ISSN: 1089-8638 [Electronic] Netherlands
PMID30099027 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Protein Kinase Inhibitors
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factor 2
  • Fibroblast Growth Factor 1
Topics
  • Animals
  • Apoptosis (drug effects, genetics)
  • Cell Line
  • Ectopic Gene Expression
  • Fibroblast Growth Factor 1 (genetics, metabolism, pharmacology)
  • Fibroblast Growth Factor 2 (genetics, metabolism, pharmacology)
  • Gene Expression
  • Humans
  • Mice
  • Mutation
  • Protein Kinase Inhibitors (pharmacology)
  • Protein Transport
  • Receptors, Fibroblast Growth Factor (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: